Sasha D. Adams

Sasha D. Adams

Auto-generated profile, based on publicly available information

Sasha D. Adams

Department of Surgery, University of Texas McGovern Medical School, Houston, Texas, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012
Verified
Journal Article
Closed access
SASasha D. Adams
Sasha D. Adams
BCBryan A. Cotton
Bryan A. Cotton
MMMary F. McGuire
Mary F. McGuire
EDEdmundo Cstr Dipasupil
Edmundo Cstr Dipasupil
JPJeanette M. Podbielski
Jeanette M. Podbielski
JHJohn B. Holcomb
John B. Holcomb
Background: Trauma centers are caring for increased proportions of elderly patients. Although age and Injury Severity Score are independently associated with mortality, trauma centers were originally designed to care for seriously injured patients without age-specific guidelines. We hypothesized that elderly patients would have different complication patterns than their younger counterparts. Methods: The trauma registry of an American College of Surgeons -verified Level I trauma center was queried for all patients older than 14 years admitted between January 2005 and December 2008. Mechanism, mortality, and complications were evaluated after dividing patients into eight age groups. Results: Of the 15,223 patients, 13% were elderly (≥65), and 86% were injured via a blunt mechanism. Increasing age correlated with fatality (all Injury Severity Scores), end-organ failure, and thromboembolic complications (deep venous thrombosis and coagulopathy). Analysis revealed a significant breakpoint at 45 years of age for mortality, decubitus ulcer, and renal failure (all p values <0.05). Infectious complications (sepsis, wound infection, and abscess) all peaked between 45 years and 65 years and then declined with increasing age. Conclusions: We document that elderly trauma patients suffer the same complications as their younger counterparts, albeit at a different rate. More importantly, we identified a “breakpoint” of increased risk of complications and mortality at greater than 45 years. Although the mechanisms behind these observations remain unknown, understanding their unique patterns may allow appropriate allocation of resources and focus research efforts on interventions that should improve outcomes. Level of Evidence: II.

1 February 2019 in The American Journal of Surgery
Verified
Journal Article
Closed access
RLRoy Lei
Roy Lei
MSMichael D. Swartz
Michael D. Swartz
JHJohn A. Harvin
John A. Harvin
BCBryan A. Cotton
Bryan A. Cotton
JHJohn B. Holcomb
John B. Holcomb
SASasha D. Adams
Sasha D. Adams

1 July 2018 in The American Journal of Surgery
Verified
Journal Article
Closed access
MGMitchell George
Mitchell George
SASasha D. Adams
Sasha D. Adams
MMMichelle K. McNutt
Michelle K. McNutt
JLJoseph D. Love
Joseph D. Love
RARondel Albarado
Rondel Albarado
JHJohn A. Harvin
John A. Harvin

1 December 2017 in Journal of Trauma and Acute Care Surgery
Verified
Journal Article
Closed access
RCRonald Chang
Ronald Chang
MSMichelle H. Scerbo
Michelle H. Scerbo
KSKarl M. Schmitt
Karl M. Schmitt
SASasha D. Adams
Sasha D. Adams
TCTimothy J. Choi
Timothy J. Choi
JHJohn B. Holcomb
John B. Holcomb
BACKGROUND: After traumatic spinal cord injury (SCI), there is increased risk of venous thromboembolism (VTE), but chemoprophylaxis (PPX) may cause expansion of intraspinal hematoma (ISH).METHODS: Single-center retrospective study of adult trauma patients from 2012 to 2015 with SCI. Exclusion criteria: VTE diagnosis, death, or discharge within 48 hours. Patients were dichotomized based on early (≤48 hours) heparinoid and/or aspirin PPX. Intraspinal hematoma expansion was diagnosed intraoperatively or by follow-up radiology. We used multivariable Cox proportional hazards to estimate the effect of PPX on risk of VTE and ISH expansion controlling for age, injury severity score (ISS), complete SCI, and mechanism as static covariates and operative spine procedure as a time-varying covariate.RESULTS: Five hundred one patients with SCI were dichotomized into early PPX (n = 260 [52%]) and no early PPX (n = 241 [48%]). Early PPX patients were less likely blunt injured (91% vs 97%) and had fewer operative spine interventions (65% vs 80%), but age (median, 43 vs 49 years), ISS (median 24 vs 21), admission ISH (47% vs 44%), and VTE (5% vs 9%) were similar. Cox analysis found that early heparinoids was associated with reduced VTE (hazard ratio [HR], 0.37; 95% confidence interval [CI], 0.16–0.84) and reduced pulmonary embolism (PE) (HR, 0.20; 95% CI, 0.06–0.69). The estimated number needed to treat with heparinoids was 10 to prevent one VTE and 13 to prevent one PE at 30 days. Early aspirin was not associated with reduced VTE or PE. Seven patients (1%) had ISH expansion, of which four were on PPX at the time of expansion. Using heparinoid and aspirin as time-varying covariates, neither heparinoids (HR, 1.90; 95% CI, 0.32–11.41) nor aspirin (HR, 3.67; 95% CI, 0.64–20.88) was associated with ISH expansion.CONCLUSION: Early heparinoid therapy was associated with decreased VTE and PE risk in SCI patients without concomitant increase in ISH expansion.LEVEL OF EVIDENCE: Therapeutic, level IV.

16 July 2024 in Trauma Surgery & Acute Care Open
Verified
Journal Article
Open access
PDF file
TETanya Egodage
Tanya Egodage
VHVanessa P Ho
Vanessa P Ho
TBTasce Bongiovanni
Tasce Bongiovanni
JKJennifer Knight-Davis
Jennifer Knight-Davis
SASasha D Adams
Sasha D Adams
BJBellal Joseph
Bellal Joseph
Background Geriatric trauma patients are an increasing population of the United States (US), sustaining a high incidence of falls, and suffer greater morbidity and mortality to their younger counterparts. Significant variation and challenges exist to optimize outcomes for this cohort, while being mindful of available resources. This manuscript provides concise summary of locoregional and national practices, including relevant updates in the triage of geriatric trauma in an effort to synthesize the results and provide guidance for further investigation. Methods We conducted a review of geriatric triage in the United States (US) at multiple stages in the care of the older patient, evaluating existing literature and guidelines. Opportunities for improvement or standardization were identified. Results Opportunities for improved geriatric trauma triage exist in the pre-hospital setting, in the trauma bay, and continue after admission. They may include physiologic criteria, biochemical markers, radiologic criteria and even age. Recent Trauma Quality Improvement Program (TQIP) Best Practices Guidelines for Geriatric Trauma Management published in 2024 support these findings. Conclusion Trauma systems must adjust to provide optimal care for older adults. Further investigation is required to provide pertinent guidance.

1 June 2009 in American Journal of Physiology-Gastrointestinal and Liver Physiology
Verified
Journal Article
Open access
PDF file
JSJames W. Suliburk
James W. Suliburk
JWJeremy L. Ward
Jeremy L. Ward
KHKenneth S. Helmer
Kenneth S. Helmer
SASasha D. Adams
Sasha D. Adams
BZBrian S. Zuckerbraun
Brian S. Zuckerbraun
DMDavid W. Mercer
David W. Mercer
Lipopolysaccharide (LPS) causes hepatic injury that is mediated, in part, by upregulation of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Ketamine has been shown to prevent these effects. Because upregulation of heme oxygenase-1 (HO-1) has hepatoprotective effects, as does carbon monoxide (CO), an end product of the HO-1 catalytic reaction, we examined the effects of HO-1 inhibition on ketamine-induced hepatoprotection and assessed whether CO could attenuate LPS-induced hepatic injury. One group of rats received ketamine (70 mg/kg ip) or saline concurrently with either the HO-1 inhibitor tin protoporphyrin IX (50 μmol/kg ip) or saline. Another group of rats received inhalational CO (250 ppm over 1 h) or room air. All rats were given LPS (20 mg/kg ip) or saline 1 h later and euthanized 5 h after LPS or saline. Liver was collected for iNOS, COX-2, and HO-1 (Western blot), NF-κB and PPAR-γ analysis (EMSA), and iNOS and COX-2 mRNA analysis (RT-PCR). Serum was collected to measure alanine aminotransferase as an index of hepatocellular injury. HO-1 inhibition attenuated ketamine-induced hepatoprotection and downregulation of iNOS and COX-2 protein. CO prevented LPS-induced hepatic injury and upregulation of iNOS and COX-2 proteins. Although CO abolished the ability of LPS to diminish PPAR-γ activity, it enhanced NF-κB activity. These data suggest that the hepatoprotective effects of ketamine are mediated primarily by HO-1 and its end product CO.